Pro-inflammatory and pro-oxidant status of pancreatic islet in vitro is controlled by TLR-4 and HO-1 pathways

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Vivot, Kevin ^a   Langlois, Allan ^a   Bietiger, William ^a   Dal, Sté Phanie ^a   Seyfritz, Elodie ^a   Pinget, Michel ^a,b   Jeandidier, Nathalie ^a,b   Maillard, Elisa ^a   Gies, Jean Pierre ^b   Sigrist, Sé Verine ^a  

^a Fédération de Médecine Translationnelle de Strasbourg   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTOPORPHYRIN COBALT; REACTIVE OXYGEN METABOLITE; RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL STRESS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; IN VITRO STUDY; MACROPHAGE MIGRATION; MACROPHAGE MIGRATION INHIBITION; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET CELL; PANCREATITIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VALIDATION STUDY; ANIMAL; BIOSYNTHESIS; GENETICS; HUMAN; INFLAMMATION; MACROPHAGE; METABOLISM; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY;

ANIMALS; CYCLOOXYGENASE 2; HEME OXYGENASE-1; HUMANS; INFLAMMATION; INTERLEUKIN-6; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MACROPHAGES; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84908409406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107656     Document Type: Article

References (74)

1. Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, et al. (2002) Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51: 2148-2157.
2. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, et al. (2001) Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50: 710-719.
3. Ryan EA, Lakey JR, Shapiro AM (2001) Clinical results after islet transplantation. J Investig Med 49: 559-562.
4. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-238.
5. Pepper AR, Gala-Lopez B, Ziff O, Shapiro AJ (2013) Current status of clinical islet transplantation. World J Transplant 3: 48-53.
6. Ryan EA, Bigam D, Shapiro AM (2006) Current indications for pancreas or islet transplant. Diabetes Obes Metab 8: 1-7.
7. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, et al. (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355: 1318-1330.
8. McCall M, Shapiro AM (2012) Update on islet transplantation. Cold Spring Harb Perspect Med 2: a007823.
9. Shapiro AM (2008) Islet transplantation-the imperative need for continued clinical trials. Nat Clin Pract Nephrol 4: 662-663.
10. Shapiro AM (2011) State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diab Rep 11: 345-354.
11. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, et al. (1996) Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45: 1161-1167.
12. Yin D, Ding JW, Shen J, Ma L, Hara M, et al. (2006) Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning. Am J Transplant 6: 60-68.
13. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, et al. (2002) Beta-cell death and mass in syngeneically transplanted islets exposed to short- and longterm hyperglycemia. Diabetes 51: 66-72.
14. Burkart V, Kolb H (1993) Protection of islet cells from inflammatory cell death in vitro. Clin Exp Immunol 93: 273-278.
15. Gysemans C, Stoffels K, Giulietti A, Overbergh L, Waer M, et al. (2003) Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents. Diabetologia 46: 1115-1123.
16. Rosenberg L, Wang R, Paraskevas S, Maysinger D (1999) Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery 126: 393-398.
17. Arita S, Nagai T, Ochiai M, Sakamoto Y, Shevlin LA, et al. (2002) Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin. Transplantation 73: 7-12.
18. Bottino R, Fernandez LA, Ricordi C, Lehmann R, Tsan MF, et al. (1998) Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 47: 316-323.
19. Bottino R, Balamurugan AN, Tse H, Thirunavukkarasu C, Ge X, et al. (2004) Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 53: 2559-2568.
20. Johansson U, Olsson A, Gabrielsson S, Nilsson B, Korsgren O (2003) Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 308: 474-479.
21. van der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DK (2007) Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 14: 288-297.
22. Piemonti L, Leone BE, Nano R, Saccani A, Monti P, et al. (2002) Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 51: 55-65.
23. Melzi R, Mercalli A, Sordi V, Cantarelli E, Nano R, et al. (2010) Role of CCL2/ MCP-1 in islet transplantation. Cell Transplant 19: 1031-1046.
24. Matsuda T, Omori K, Vuong T, Pascual M, Valiente L, et al. (2005) Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant 5: 484-493.
25. Tran PO, Gleason CE, Robertson RP (2002) Inhibition of interleukin-1betainduced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function. Diabetes 51: 1772-1778.
26. Xenos ES, Stevens RB, Sutherland DE, Lokeh A, Ansite JD, et al. (1994) The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts. Transplantation 57: 1208-1212.
27. Alegre ML, Leemans J, Le Moine A, Florquin S, De Wilde V, et al. (2008) The multiple facets of toll-like receptors in transplantation biology. Transplantation 86: 1-9.
28. Wen L, Peng J, Li Z, Wong FS (2004) The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J Immunol 172: 3173-3180.
29. Vives-Pi M, Somoza N, Fernandez-Alvarez J, Vargas F, Caro P, et al. (2003) Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol 133: 208-218.
30. Goldberg A, Parolini M, Chin BY, Czismadia E, Otterbein LE, et al. (2007) Toll-like receptor 4 suppression leads to islet allograft survival. FASEB J 21: 2840-2848.
31. Kruger B, Yin N, Zhang N, Yadav A, Coward W, et al. (2010) Islet-expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation. Eur J Immunol 40: 2914-2924.
32. Shen XD, Ke B, Zhai Y, Gao F, Busuttil RW, et al. (2005) Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J - Transplant 5: 1793-1800.
33. Maines MD (1997) The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554.
34. Zhang X, Goncalves R, Mosser DM (2008) The isolation and characterization of murine macrophages. Curr Protoc Immunol Chapter 14: Unit 14 11.
35. Sutton R, Peters M, McShane P, Gray DW, Morris PJ (1986) Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 42: 689-691.
36. Sigrist S, Oberholzer J, Bohbot A, Esposito G, Mandes K, et al. (2004) Activation of human macrophages by allogeneic islets preparations: inhibition by AOP-RANTES and heparinoids. Immunology 111: 416-421.
37. Dal-Ros S, Oswald-Mammosser M, Pestrikova T, Schott C, Boehm N, et al. (2010) Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats. Gastroenterology 138: 1574-1584.
38. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
39. Nilsson B, Ekdahl KN, Korsgren O (2011) Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr Opin Organ Transplant 16: 620-626.
40. Wang H, Ferran C, Attanasio C, Calise F, Otterbein LE (2011) Induction of protective genes leads to islet survival and function. J Transplant 2011: 141898.
41. Ye J, Laychock SG (1998) A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1beta. Endocrinology 139: 4155-4163.
42. Asadullah K, Sterry W, Volk HD (2003) Interleukin-10 therapy-review of a new approach. Pharmacol Rev 55: 241-269.
43. Hakim J (1993) [Reactive oxygen species and inflammation]. C R Seances Soc Biol Fil 187: 286-295.
44. Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, et al. (2006) A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cy-clohex- 1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4- mediated cytokine production through suppression of intracellular signaling. Mol Pharmacol 69: 1288-1295.
45. Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H (2008) TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur J Pharmacol 584: 40-48.
46. Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, et al. (2001) Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50: 1983-1991.
47. Wang H, Lee SS, Dell'Agnello C, Tchipashvili V, d'Avila JC, et al. (2006) Bilirubin can induce tolerance to islet allografts. Endocrinology 147: 762-768.
48. Wang H, Lee SS, Gao W, Czismadia E, McDaid J, et al. (2005) Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. Diabetes 54: 1400-1406.
49. Nakahira K, Kim HP, Geng XH, Nakao A, Wang X, et al. (2006) Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROSinduced trafficking of TLRs to lipid rafts. J Exp Med 203: 2377-2389.
50. Remy S, Blancou P, Tesson L, Tardif V, Brion R, et al. (2009) Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity. J Immunol 182: 1877-1884.
51. Chen X, Zhang Z, Su C, Gu W, Li H, et al. (2010) Protective effect of heme oxygenase-1 to pancreas islet xenograft. J Surg Res 164: 336-343.
52. Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN (2006) Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 38: 1654-1661.
53. Hildebrand D, Sahr A, Wolfle SJ, Heeg K, Kubatzky KF (2012) Regulation of Toll-like receptor 4-mediated immune responses through Pasteurella multocida toxin-induced G protein signalling. Cell Commun Signal 10: 22.
54. Moberg L, Korsgren O, Nilsson B (2005) Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABOcompatible blood. Clin Exp Immunol 142: 125-131.
55. Danner S, Sigrist S, Moreau F, Mandes K, Vodouhe C, et al. (2008) Influence of rapamycin on rat macrophage viability and chemotaxis toward allogenic pancreatic islet supernates. Transplant Proc 40: 470-472.
56. Sigrist S, Ebel N, Langlois A, Bosco D, Toso C, et al. (2005) Role of chemokine signaling pathways in pancreatic islet rejection during allo- and xenotransplantation. Transplant Proc 37: 3516-3518.
57. Vivot K, Jeandidier N, Dollinger C, Bietiger W, Pinget M, et al. (2011) Role of islet culture on angiogenic and inflammatory mechanisms. Transplant Proc 43: 3201-3204.
58. Barshes NR, Wyllie S, Goss JA (2005) Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 77: 587-597.
59. Persaud SJ, Burns CJ, Belin VD, Jones PM (2004) Glucose-induced regulation of COX-2 expression in human islets of Langerhans. Diabetes 53 Suppl 1: S190-192.
60. Seibert K, Masferrer JL (1994) Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor 4: 17-23.
61. Sorli CH, Zhang HJ, Armstrong MB, Rajotte RV, Maclouf J, et al. (1998) Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci U S A 95: 1788-1793.
62. Heitmeier MR, Kelly CB, Ensor NJ, Gibson KA, Mullis KG, et al. (2004) Role of cyclooxygenase-2 in cytokine-induced beta-cell dysfunction and damage by isolated rat and human islets. J Biol Chem 279: 53145-53151.
63. Juang JH, Kuo CH (2010) Effects of cyclooxygenase-2 inhibitor and adenosine triphosphate-sensitive potassium channel opener in syngeneic mouse islet transplantation. Transplant Proc 42: 4221-4224.
64. Cowley MJ, Weinberg A, Zammit NW, Walters SN, Hawthorne WJ, et al. (2012) Human islets express a marked proinflammatory molecular signature prior to transplantation. Cell Transplant 21: 2063-2078.
65. Armann B, Hanson MS, Hatch E, Steffen A, Fernandez LA (2007) Quantification of basal and stimulated ROS levels as predictors of islet potency and function. Am J Transplant 7: 38-47.
66. Lenzen S, Drinkgern J, Tiedge M (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20: 463-466.
67. Welsh N, Margulis B, Borg LA, Wiklund HJ, Saldeen J, et al. (1995) Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulindependent diabetes mellitus. Mol Med 1: 806-820.
68. Sklavos MM, Bertera S, Tse HM, Bottino R, He J, et al. (2010) Redox modulation protects islets from transplant-related injury. Diabetes 59: 1731-1738.
69. Lee TS, Chau LY (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8: 240-246.
70. Zhang YC, Pileggi A, Agarwal A, Molano RD, Powers M, et al. (2003) Adenoassociated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes 52: 708-716.
71. Gao Q, Ma LL, Gao X, Yan W, Williams P, et al. (2010) TLR4 mediates early graft failure after intraportal islet transplantation. Am J Transplant 10: 1588-1596.
72. Ziolkowski AF, Popp SK, Freeman C, Parish CR, Simeonovic CJ (2012) Heparan sulfate and heparanase play key roles in mouse beta cell survival and autoimmune diabetes. J Clin Invest 122: 132-141.
73. Itoh T, Sugimoto K, Shimoda M, Chujo D, Takita M, et al. (2011) Establishment of a prolonged pancreas preservation model for islet isolation research in mice. Islets 3: 376-380.
74. Forman K, Vara E, Garcia C, Kireev R, Cuesta S, et al. (2011) Effect of a combined treatment with growth hormone and melatonin in the cardiological aging on male SAMP8 mice. J Gerontol A Biol Sci Med Sci 66: 823-834.